Related Experiment Video
Updated: Dec 22, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
967
Hepatic volume changes post-selective internal radiation therapy with 90 Y microspheres.
Frederick Ong1, Jonathan Tibballs1
1Department of Radiology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Summary
Selective internal radiation therapy (SIRT) with 90Y microspheres effectively induces future liver remnant (FLR) hypertrophy in patients with right liver lobe malignancy. This liver-directed therapy supports surgical resection eligibility and treatment of liver tumors.
Area of Science:
- Hepatobiliary surgery
- Interventional radiology
- Oncology
Background:
- Selective internal radiation therapy (SIRT) using 90Y microspheres is an alternative to portal vein embolization for inducing future liver remnant (FLR) hypertrophy.
- This technique aims to reduce postoperative morbidity and increase surgical resection eligibility for liver malignancies.
- Unlike portal vein embolization, SIRT also treats liver tumors and mitigates progression during hypertrophy.
Purpose of the Study:
- To evaluate hepatic volume changes following SIRT with 90Y microspheres.
- To assess the efficacy of SIRT in inducing FLR hypertrophy for patients with right liver lobe malignancy.
Main Methods:
- Retrospective analysis of 29 patients with right liver lobe malignancy treated with SIRT between August 2012 and November 2016.
- Liver volumes were measured using CT or MRI before treatment and at 3, 6, and 12 months post-SIRT.
Main Results:
- A mean increase in FLR volume of 37.2% at 3 months, 42.6% at 6 months, and 63.5% at 12 months was observed.
- The whole liver volume showed a mean decrease of -13.3% at 12 months.
- Primary liver malignancies (HCC, cholangiocarcinoma) and metastases (colorectal, ampullary) were present in the study cohort.
Conclusions:
- SIRT of the right liver lobe effectively induces compensatory hypertrophy of the left liver lobe (FLR).
- The findings support the use of SIRT in selected patients with right liver lobe malignancy to facilitate liver resection.

